Reducing postischemic reperfusion damage in neonates using a terminal warm substrate-enriched blood cardioplegic

Annals of Thoracic Surgery

Volumn 70, Issue 3, 2000, Pages 765-770

  Kronon, Michael T ^b   Allen, Bradley S ^a   Rahman, Shaikh ^b   Wang, Tingrong ^b   Tayyab, N Arif ^b   Bolling, Kirk S ^b   Ilbawi, Michel N ^b  

^a ADVOCATE CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE KINASE INHIBITOR; ASPARTIC ACID; CARDIOPLEGIC AGENT; GLUTAMIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; CARDIOPLEGIA; CONTROLLED STUDY; CORONARY VASCULAR RESISTANCE; HEART ARREST; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART STRESS; HYPOXIA; NEWBORN; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SWINE;

ADENOSINE TRIPHOSPHATE; ANIMAL; ANIMALS, NEWBORN; ASPARTIC ACID; BLOOD; CARDIOPLEGIC SOLUTIONS; GLUTAMIC ACID; HEART; HEMODYNAMICS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXYGEN CONSUMPTION; SUPPORT, NON-U.S. GOV'T; SWINE; TEMPERATURE;

EID: 0033806828     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(00)01714-8     Document Type: Article

References (27)

1. Myocardial protection management during adult cardiac operations
2. Reducing postischemic damage by temporary modification of reperfusate calcium, potassium, pH, and osmolarity
3. Myocardial preservation in the immature heart
4. Myocardial management during cardiac surgery with cardiopulmonary bypass
5. Studies of controlled reperfusion after ischemia XV: Immediate functional recovery after 6 hours of regional ischemia by careful control of conditions of reperfusion and composition of reperfusate
6. Cardioplegia protection of the child's heart
7. Myocardial protection in the immature heart
8. Inadequate myocardial protection with cold cardioplegic arrest during repair of tetralogy of Fallot
9. Safety of prolonged aortic clamping with blood cardioplegia. III: Aspartate enrichment of glutamate-blood cardioplegia in energy depleted hearts after ischemic and reperfusion injury
10. Myocardial protection in normal and hypoxically stressed neonatal hearts: The superiority of blood versus crystalloid cardioplegia
11. The role of cardioplegia induction temperature and amino acid enrichment in neonatal myocardial protection
12. Dose dependency of L-arginine in neonatal myocardial protection: The nitric oxide paradox
13. Prevention of the hypoxic/reoxygenation injury using a leukocyte depleting filter
14. Studies of hypoxemic/reoxygenation injury: Without aortic clamping. III. Comparison of the magnitude of damage by hypoxemia/reoxygenation versus ischemia/reperfusion
15. Warm blood cardioplegic induction: An underused modality
16. Accelerated myocardial metabolic recovery with terminal warm blood cardioplegia
17. Studies of myocardial protection in the immature heart. I. Enhanced tolerance of immature versus adult myocardium to global ischemia with reference to metabolic differences
18. Chronic hypoxemia depresses global ventricular function and predisposes to depletion of high energy phosphates during cardioplegic arrest: Implications for surgical repair of cyanotic congenital heart defects
19. Left heart function in children with tetralogy of Fallot before and after palliative or corrective surgery
20. Effects of age and ischemic times on biochemical evidence of myocardial injury after pediatric cardiac operations
21. Studies of hypoxic/reoxygenation injury: Without aortic clamping. VIII. Counteraction of oxidant damage by exogenous glutamate and aspartate
22. Effect of oxygen tension and cardiovascular operations on the myocardial antioxidant enzyme activities in patients with tetralogy of Fallot and aorta-coronary bypass
23. Severe myocardial dysfunction during extracorporeal membrane oxygenation
24. The detrimental effects of cardiopulmonary bypass in cyanotic infants: Preventing the reoxygenation injury
25. Myocardial adenosine triphosphate content as a measure of metabolic and functional myocardial protection in children undergoing cardiac operation
26. Myocardial protection in cyanotic neonatal lambs
27. Left ventricular dysfunction after open repair of simple congenital heart defects in infants and children: Quantitation with the use of a conductance catheter immediately after bypass